首页> 外文期刊>British journal of ophthalmology >Retinal toxicity of intravitreal tenecteplase in the rabbit.
【24h】

Retinal toxicity of intravitreal tenecteplase in the rabbit.

机译:玻璃体内替奈普酶对家兔的视网膜毒性。

获取原文
获取原文并翻译 | 示例
       

摘要

Aim: To investigate the retinal toxicity of intravitreal injection of a novel fibrinolytic tenecteplase in rabbit eyes. METHODS: Tenecteplase (25-350 micro g in 0.1 ml BSS) was injected into the vitreous cavity of normal rabbit eyes. Control (fellow) eyes received 0.1 ml of BSS. One day, 1 week, and 2 months post-injection, the eyes were examined by slit lamp biomicroscopy, indirect ophthalmoscopy, and electroretinography, and then harvested for histopathological examination. RESULTS: No evidence of retinal toxicity was seen with tenecteplase doses up to and including 50 micro g. At a dose of 150 micro g ophthalmoscopy was normal, but histology showed mild retinal damage in the inner nuclear layer and electroretinography showed a temporary reduction in B-wave amplitude. At doses of 200 micro g and above, there was evidence of retinal toxicity on electroretinography, ophthalmoscopy, and histology. Ophthalmoscopic findings included vitreal fibrosis, retinal necrosis and tractional retinal detachment and light microscopy revealed necrosis of retinal pigment epithelium and other retinal layers. Damage was centred around the injection site but was more widespread with the higher doses. CONCLUSION: A dose of 50 micro g tenecteplase appears safe for intravitreal injection in the rabbit. Tenecteplase could have potential applications in the treatment of submacular haemorrhage and retinal vein occlusion.
机译:目的:探讨玻璃体内注射新型纤溶性替奈普酶对兔眼的视网膜毒性。方法:将替奈普酶(25 ml至350 micro g,0.1 ml BSS)注入正常兔眼的玻璃体腔中。对照(同种)眼睛接受0.1 ml BSS。注射后1天,1周和2个月,通过裂隙灯生物显微镜,间接检眼镜和视网膜电图检查眼睛,然后收集进行组织病理学检查。结果:使用替奈普酶剂量不超过50微克时,未见视网膜毒性的证据。剂量为150微克时,眼底镜检查是正常的,但组织学检查显示内核层有轻度视网膜损伤,而视网膜电图检查则显示B波振幅暂时降低。在200微克及以上的剂量下,有证据表明视网膜电图,检眼镜和组织学对视网膜有毒性。眼底镜检查包括玻璃体纤维化,视网膜坏死和牵引性视网膜脱离,光学显微镜检查显示视网膜色素上皮和其他视网膜层坏死。损害集中在注射部位周围,但随着剂量的增加,损害更加普遍。结论:50微克的替奈普酶对兔玻璃体内注射是安全的。替奈普酶可能在治疗黄斑下出血和视网膜静脉阻塞方面有潜在的应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号